Skin Health Institute has a proud history of collaborating with international and local pharmaceutical companies as well as National Collaborative Groups on a variety of clinical trials and research projects. The Skin Health Institute is also signatory to an agreement as collaborator with Probity Medical Research, a Canadian-based clinical trials consortium presided over by Dr Kim Papp, who is a world authority on designing, implementing and conducting clinical trials.
Successful treatments approved for use in Australia that were tested by our Clinical Trials Department include:
|Psoriasis||Atopic Dermatitis||Skin Cancer/ Actinic Keratosis||Hidradenitis Suppurativa||Rosacea/Chronic Spontaneous Urticaria|
|Taltz||Dupixent||PDT Metvix & Daylight PDT|
|Enbrel (also for Psoriatic Arthritis)|